PURPOSE: We sought to determine the association between health-related quality of life (HRQOL) and graft function in renal transplant recipients. DESIGN AND METHODS: We enrolled 577 kidney transplant recipients aged 18-74 years (response rate 87%). Recipients with multiple or multi-organ transplantation, creatine kinase >200 U/L, acute renal failure or cellular rejection (n = 64), and without creatinine assessments in 3 months pre-enrollment (n = 127) were excluded. The questionnaire included Euro QOL 5 Dimensions (EQ-5D), Health Utility Index III (HUI-III), Kidney Disease Quality of Life-36 (KDQOL36) which include a generic section (RAND SF-12). Data on medical conditions, therapy regimens, and biochemistry results were extracted from clinical charts. We used general linear models adjusted for demographic, socioeconomic, and clinical characteristics to assess the association between HRQOL and severity of chronic kidney disease (CKD). RESULTS: Patients with more advanced CKD were more likely to be African-American, covered by public insurance, more likely to have shorter time after transplantation, higher phosphorus and lower hemoglobin, serum albumin, and calcium levels. All HRQOL scales were inversely associated with CKD severity. All associations were robust to adjustment for possible confounders. CONCLUSIONS: Several health-related quality of life dimensions may be affected by poor renal function after transplantation.
PURPOSE: We sought to determine the association between health-related quality of life (HRQOL) and graft function in renal transplant recipients. DESIGN AND METHODS: We enrolled 577 kidney transplant recipients aged 18-74 years (response rate 87%). Recipients with multiple or multi-organ transplantation, creatine kinase >200 U/L, acute renal failure or cellular rejection (n = 64), and without creatinine assessments in 3 months pre-enrollment (n = 127) were excluded. The questionnaire included Euro QOL 5 Dimensions (EQ-5D), Health Utility Index III (HUI-III), Kidney Disease Quality of Life-36 (KDQOL36) which include a generic section (RAND SF-12). Data on medical conditions, therapy regimens, and biochemistry results were extracted from clinical charts. We used general linear models adjusted for demographic, socioeconomic, and clinical characteristics to assess the association between HRQOL and severity of chronic kidney disease (CKD). RESULTS:Patients with more advanced CKD were more likely to be African-American, covered by public insurance, more likely to have shorter time after transplantation, higher phosphorus and lower hemoglobin, serum albumin, and calcium levels. All HRQOL scales were inversely associated with CKD severity. All associations were robust to adjustment for possible confounders. CONCLUSIONS: Several health-related quality of life dimensions may be affected by poor renal function after transplantation.
Authors: Jaroslav Rosenberger; Jitse P van Dijk; Iveta Nagyova; Ivan Zezula; Andrea Madarasova Geckova; Robert Roland; Wim J A van den Heuvel; Johan W Groothoff Journal: Transplantation Date: 2006-05-15 Impact factor: 4.939
Authors: Brian J Nankivell; Richard J Borrows; Caroline L-S Fung; Philip J O'Connell; Richard D M Allen; Jeremy R Chapman Journal: N Engl J Med Date: 2003-12-11 Impact factor: 91.245
Authors: Manjula Kurella; Christine Ireland; Mark A Hlatky; Michael G Shlipak; Kristine Yaffe; Stephen B Hulley; Glenn M Chertow Journal: Am J Kidney Dis Date: 2004-05 Impact factor: 8.860
Authors: Upali W Jayasinghe; Judith Proudfoot; Christopher A Barton; Cheryl Amoroso; Chris Holton; Gawaine Powell Davies; Justin Beilby; Mark F Harris Journal: Health Qual Life Outcomes Date: 2009-06-03 Impact factor: 3.186
Authors: Ana C Ricardo; Eileen Hacker; Claudia M Lora; Lynn Ackerson; Karen B DeSalvo; Alan Go; John W Kusek; Lisa Nessel; Akinlolu Ojo; Raymond R Townsend; Dawei Xie; Carol E Ferrans; James P Lash Journal: Ethn Dis Date: 2013 Impact factor: 1.847
Authors: Rachel C Forbes; Irene D Feurer; David LaNeve; Beatrice P Concepcion; Christianna Gamble; Scott A Rega; C Wright Pinson; David Shaffer Journal: Clin Transplant Date: 2018-03-30 Impact factor: 2.863
Authors: Nanna von der Lippe; Bård Waldum; Fredrik B Brekke; Amin A G Amro; Anna Varberg Reisæter; Ingrid Os Journal: BMC Nephrol Date: 2014-12-02 Impact factor: 2.388
Authors: Jacie T Cooper; Andrew Lloyd; Juan Jose Garcia Sanchez; Elisabeth Sörstadius; Andrew Briggs; Phil McFarlane Journal: Health Qual Life Outcomes Date: 2020-09-21 Impact factor: 3.186